Neonatal neurobehavior effects following buprenorphine versus methadone exposure
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Aim: To determine the effects of in utero exposure to methadone or buprenorphine on infant neurobehavior. Design: Three sites from the M aternal O pioid T reatment: H uman E xperimental R esearch (MOTHER) study, a double‐blind, double‐dummy, randomized clinical trial participated in this substudy. Setting: Medical Centers that provided comprehensive maternal care to opioid‐dependent pregnant women in B altimore, MD, P rovidence, RI and V ienna, A ustria. Participants: Thirty‐nine full‐term infants. Measurements: The Neonatal Intensive Care Unit (NICU) N etwork N eurobehavioral S cale (NNNS) was administered to a subgroup of infants on postpartum days 3, 5, 7, 10, 14–15 and 28–30. Findings: While neurobehavior improved for both medication conditions over time, infants exposed in utero to buprenorphine exhibited fewer stress‐abstinence signs (P < 0.001), were less excitable (P < 0.001) and less over‐aroused (P < 0.01), exhibited less hypertonia (P < 0.007), had better self‐regulation (P < 0.04) and required less handling (P < 0.001) to maintain a quiet alert state relative to in utero methadone‐exposed infants. Infants who were older when they began morphine treatment for withdrawal had higher self‐regulation scores (P < 0.01), and demonstrated the least amount of excitability (P < 0.02) and hypertonia (P < 0.02) on average. Quality of movement was correlated negatively with peak NAS score (P < 0.01), number of days treated with morphine for NAS (P < 0.01) and total amount of morphine received (P < 0.03). Excitability scores were related positively to total morphine dose (P < 0.03). Conclusion: While neurobehavior improves during the first month of postnatal life for in utero agonist medication‐exposed neonates, buprenorphine exposure results in superior neurobehavioral scores and less severe withdrawal than does methadone exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005359 · Cited by 986
Self-citationLester, B. M., Tronick, E. Z., LaGasse, L., Seifer, R., Bauer, C. R., Shankaran, S., Bada, H. S., Wright, L. L., Smeriglio, V. L., Lu, J., et al. (2002) · PEDIATRICS · doi:10.1542/peds.110.6.1182 · Cited by 317 · cited 2×
“The NICU Network Neurobehavioral Scale (NNNS) has been used to describe the neurobehavioral effects of fetal exposure to opiates [1,11–13], cocaine [14] methamphetamines [15] and nicotine [16,25].”
Self-citationSmoking during pregnancy and newborn neurobehavior
Law, K. L., Stroud, L. R., LaGasse, L. L., Niaura, R., Liu, J., & Lester, B. M. (2003) · PEDIATRICS · doi:10.1542/peds.111.6.1318 · Cited by 307
Self-citationTreatment of opioid-dependent pregnant women: Clinical and research issues
Jones, H. E., Martin, P. R., Heil, S. H., Kaltenbach, K., Selby, P., Coyle, M. G., Stine, S. M., O'Grady, K. E., Arria, A. M., & Fischer, G. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.10.007 · Cited by 191 · cited 3×
“Details of this protocol have been published elsewhere [18].”
Self-citationHistory and description of the Neonatal Intensive Care Unit Network Neurobehavioral Scale
Lester, B. M., & Tronick, E. Z. (2004) · PEDIATRICS · doi:10.1542/peds.113.s2.634 · Cited by 154
Self-citationBuprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes
Johnson, R. E., Jones, H. E., Jasinski, D. R., Svikis, D. S., Haug, N. A., Jansson, L. M., Kissin, W. B., Alpan, G., Lantz, M. E., Cone, E. J., et al. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00194-0 · Cited by 125
Self-citationMaternal Smoking during Pregnancy and Newborn Neurobehavior: Effects at 10 to 27 Days
Stroud, L. R., Paster, R. L., Papandonatos, G. D., Niaura, R., Salisbury, A. L., Battle, C., Lagasse, L. L., & Lester, B. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.07.048 · Cited by 102 · cited 2×
“The NICU Network Neurobehavioral Scale (NNNS) has been used to describe the neurobehavioral effects of fetal exposure to opiates [1,11–13], cocaine [14] methamphetamines [15] and nicotine [16,25].”
Self-citation
Cited by
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122957 · Cited by 1,388
“Both buprenorphine and methadone treatment are associated with reduced overdose risk and improved maternal and fetal outcomes in pregnancy (19, 44, 51, 72).”
Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions
Connery, H. S. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000075 · Cited by 576
Developmental Consequences of Fetal Exposure to Drugs: What We Know and What We Still Must Learn
Ross, E. J., Graham, D. L., Money, K. M., & Stanwood, G. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.147 · Cited by 476
Methadone and Buprenorphine for the Management of Opioid Dependence in Pregnancy
Jones, H. E., Finnegan, L. P., & Kaltenbach, K. (2012) · Drugs · doi:10.2165/11632820-000000000-00000 · Cited by 289
Self-citationRecommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus
Dematteis, M., Auriacombe, M., D’Agnone, O., Somaini, L., Szerman, N., Littlewood, R., Alam, F., Alho, H., Benyamina, A., Bobes, J., et al. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1409722 · Cited by 141
“Buprenorphine treatment has advantages over methadone for outcomes of fetal well-being (third-trimester evaluation of fetal heart rate/movements before and after dosing), neonatal abstinence syndrome, and neonatal neurobehavioral functioning [108].”
BackgroundConvertino, I., Sansone, A. C., Marino, A., Galiulo, M. T., Mantarro, S., Antonioli, L., Fornai, M., Blandizzi, C., & Tuccori, M. (2016) · Drug Safety · doi:10.1007/s40264-016-0435-8 · Cited by 32
Metadata
- Authors
- Coyle, M. G., Salisbury, A. L., Lester, B. M., Jones, H. E., Lin, H., Graf‐Rohrmeister, K., & Fischer, G.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2012-10-29
- Volume
- 107
- Issue
- S1
- Pages
- 63-73
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W1547354143
- Cited by
- 92
- References
- 7
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.